Colony‑stimulating factor CSF2 mediates the phenotypic plasticity of small‑cell lung cancer by regulating the p‑STAT3/MYC pathway
Hui Li(Jilin Province Tumor Hospital), Ying Cheng(First Affiliated Hospital of Xi'an Jiaotong University)
Cited by 19
Related Papers
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
|The Lancet Oncology|2023|243